Search filters

List of works by Michele De Tursi

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression

scientific article published on 03 July 2019

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

scientific article published on 27 February 2019

Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction

scientific article published on 11 April 2017

Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib

scientific article published on 16 March 2020

An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors

scientific article published on May 2012

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r

scientific article published on 04 February 2020

Arterial thrombosis in ambulatory cancer patients treated with chemotherapy

scientific article published on 5 November 2010

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.

scientific article published on 28 September 2016

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey

scientific article

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

scientific article

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

scientific article published on 15 July 2020

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

scientific article published on 22 October 2020

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

scientific article published on November 2014

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

scientific article published on 30 May 2020

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 02 January 2019

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

scientific article published on 26 May 2017

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.

scientific article published on 20 August 2015

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

scientific article published on 15 November 2019

Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment

scientific article published on 17 March 2020

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

scientific article published on 12 December 2018

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

scientific article published on 16 November 2020

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

scientific article published on 20 April 2013

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells

scientific article published on 21 September 2018

Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study

scientific article published on 04 August 2020

Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer

scientific article

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

scientific article published on 07 January 2020

Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study

scientific article published on 16 May 2020

Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report.

scientific article

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study

scientific article published on 22 March 2018

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts.

scientific article

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

scientific article published on 15 January 2018

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study

scientific article published on 01 February 2020

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

scientific article published on 15 October 2019

Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy

scientific article published on 30 August 2010

Lapatinib in second-line treatment for metastatic breast cancer: rapid clinical benefit and long-term response.

scientific article published in November 2013

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

scientific article published on 23 May 2020

Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.

scientific article published on 13 February 2014

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

scientific article published on 10 October 2012

Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients

scientific article published on 01 July 2019

Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives.

scientific article

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice.

scientific article published on 7 December 2017

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

scientific article published on 15 July 2017

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

scientific article

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes

scientific article published on 07 August 2019

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

scientific article published on 10 December 2018

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study

scientific article published on 13 December 2019

Persistence and adherence to androgen deprivation therapy in men with prostate cancer: an administrative database study

scientific article published on 12 December 2019

Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis

scientific article published on 12 September 2012

Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma

scientific article published on 23 June 2020

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

scientific article

Relationship and Predictive Role of the Dual Expression of FGFR and IL-8 in Metastatic Renal Cell Carcinoma Treated with Targeted Agents

scientific article

Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.

scientific article published in June 2007

Rivaroxaban for Cancer-associated Cardiac Thrombosis

scientific article published on 11 June 2015

Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study

scientific article

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

scientific article published on 29 August 2019

Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts.

scientific article

Speed Rate (SR) as a new dynamic index of melanoma behavior

scientific article published on 14 May 2020

The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides

scientific article published on July 2004

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status

scientific article published on 16 March 2016

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

scientific article published on 29 January 2020

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study

scientific article published on 06 July 2019

Paulina is supported by:

About Paulina

Help